Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill
NCT ID: NCT01823484
Last Updated: 2014-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients
NCT02355873
Hemodialysis Without Anticoagulation in Intensive Care Unit
NCT00242398
Safety and Efficacy of Intermittent Renal Replacement Therapy Using CITRASATE in Critically-ill Patients
NCT05313230
A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
NCT01318811
Study Comparing High Cut-off Haemofiltration With Standard Haemofiltration in Acute Renal Failure
NCT00912184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AN 69 ST hemofilter
Use AN 69 ST hemofilter during CRRT
AN 69 ST hemofilter
AN 69 hemofilter
Use AN 69 hemofilter during CRRT
AN 69 hemofilter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AN 69 ST hemofilter
AN 69 hemofilter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted to ICU and need CRRT
* anticipated survival time \>72h
Exclusion Criteria
* heparin associated thrombocytopenia
* pregnancy or lactation
* using other anticoagulate drugs
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhongda Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiaohua Qiu
physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xiaohua Qiu
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
112233
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.